[therapeutic] in children aged 1 month– 5 years and 6 – 11
years].
.Ganciclovir p. 407.
.Hydroxycarbamide p.^552.
.Lacosamide p. 201.
.Levonorgestrel p. 508 [higher dose in emergency
contraception].
.Levonorgestrel p. 508 [update to effective duration for
Levosert®intra-uterine device].
.Levonorgestrel p. 508 [update to timing for emergency
contraception].
.Lisdexamfetamine mesilate p. 230 [dose for children
updated].
.Lopinavir with ritonavir p. 425 [update to age-range—
now licensed from 14 days].
.Macrogol 3350 with potassium chloride, sodium
bicarbonate and sodium chloride p. 42.
.Naloxone hydrochloride p. 842 [clarification of maximum
initial dose in children aged 1 month– 11 years for
overdosage with opioids].
.Papaveretum p. 287 [clarification of dosing].
.Raltegravir p. 411 [all doses updated].
.Sodium nitrite p. 839.
.Sodium thiosulfate p. 839.
.Teicoplanin p. 325 [all doses updated].
.Tramadol with paracetamol p. 290 [clarification of dosing].
.Ustekinumab p. 748 [moderate-to-severe plaque psoriasis].
.Vancomycin p. 325.
Classification changes
Classification changes that appear in the print edition ofBNF
for Children 2018 – 2019 :
New names
Name changes that appear in the print edition ofBNF for
Children 2018 – 2019 ::
Deleted preparations
Preparations discontinued in the print edition ofBNF for
Children 2018 – 2019 :
New preparations
New preparations that appear in the print edition ofBNF for
Children 2018 – 2019 :
.Cetraxal®[ciprofloxacin ear drops p. 690 ].
.Chenodeoxycholic acid[chenodeoxycholic acid capsules
p. 64 ].
.Cubicin®[daptomycin p. 355 ].
.Cystadrops®[mercaptamine p. 605 ].
.Emend®[aprepitant p. 263 ].
.Galafold®[migalastat p. 607 ].
.Harvoni®[ledipasvir with sofosbuvir p. 401 ].
.Hemlibra®[emicizumab p. 83 ].
.Infanrix Hexa®[diphtheria with tetanus, pertussis,
hepatitis b, poliomyelitis and haemophilus influenzae type
b vaccine p. 790 ].
.Kyleena®[levonorgestrel intrauterine device p. 508 ].
.Mylotarg®[gemtuzumab ozogamicin p. 528 ].
.Neomag®[magnesium glycerophosphate chewable tablets
p. 596 ].
.Otosporin®[hydrocortisone with neomycin and polymyxin
B sulfate p. 693 ].
.Ravicti®[glycerol phenylbutyrate p. 615 ].
.RoActemra®preparations [tocilizumab p. 640 ].
.Rupatadine [rupatadine tablets p. 177 ].
.Simponi®[golimumab p. 645 ].
.Sovaldi®[sofosbuvir p. 402 ].
.Spinraza®[nusinersen p. 647 ].
.Spiriva Respimat®[tiotropium p. 153 ].
.Stelara®[ustekinumab p. 748 ].
.Strensiq®[asfotase alfa p. 608 ].
.Symtuza®[darunavir with cobicistat, emtricitabine and
tenofovir alafenamide p. 424 ].
.Tasigna®[nilotinib p. 560 ].
.Thealoz Duo®[sodium hyaluronate and trehalose p. 674 ].
.Trospium chloride p. 490.
.Trumenba®[meningococcal group B vaccine (rDNA,
component, adsorbed) p. 792 ].
.Truvada®[emtricitabine with tenofovir disoproxil p.^420 ].
.Valcyte®[valganciclovir p. 408 ].
.Vemlidy®[tenofovir alafenamide p. 400 ].
.Xaggitin®XL [methylphenidate hydrochloride p. 227 ].
.Xylonor®[lidocaine with cetrimide p. 827 ].
.Yervoy®[ipilimumab p. 529 ].xx BNFC 2018 – 2019